Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
Colorectal Neoplasms
|
0.200 |
AlteredExpression
|
group |
BEFREE |
We performed a comparative immunohistochemical analysis of p73, p53, and p21ras proteins in primary colorectal tumor with matched normal mucosa and metastasis from 204 patients with colorectal cancer.
|
19956069 |
2010 |
Colorectal Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
The inhibitory effects of yogurt consisting of milk fermented by Lactobacillus delbrueckii subsp. bulgaricus strain 2038 and Streptococcus salivarius subsp. thermophilus strain 1131 on formation of colonic aberrant crypt foci (ACF) in rats and also on development of colorectal tumors in transgenic mice harboring human prototype c-Ha-ras genes (rasH2 mice) were examined.
|
20660995 |
2010 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
LHGDN |
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone.
|
18621636 |
2008 |
Colorectal Neoplasms
|
0.200 |
Biomarker
|
group |
LHGDN |
Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
|
18296105 |
2008 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
LHGDN |
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
|
18676755 |
2008 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
LHGDN |
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin.
|
16760302 |
2006 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
CLINVAR |
APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
|
16478791 |
2006 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
LHGDN |
Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors.
|
16174078 |
2005 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
LHGDN |
Persistence of K-ras mutations in plasma after colorectal tumor resection.
|
15816642 |
2005 |
Colorectal Neoplasms
|
0.200 |
AlteredExpression
|
group |
LHGDN |
Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.
|
16356174 |
2005 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
The aim of this work was to study the prevalence of mutations at codons 12, 13 and 61 of the Ki-ras gene in 37 colorectal tumors from Mexican patients and to correlate them with clinical data.
|
12908779 |
2003 |
Colorectal Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
The number of colorectal tumors per mouse induced by 1,2-dimethylhydrazine in transgenic (Tg) mice carrying human c-Ha-ras genes was significantly reduced by ingestion of apple pectin (AP) or a culture condensate of Bifidobacterium longum(MB) compared with a control diet and non-Tg mice.
|
11370830 |
2001 |
Colorectal Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
The number and tumor score of colorectal tumors induced by 1,2-dymethylhydrazine in transgenic (Tg) mice carrying human c-Ha-ras genes were significantly reduced by ingestion of apple pectin (AP) or a culture condensate of Bifidobacterium longum (MB) when compared with a control diet.
|
11109558 |
2000 |
Colorectal Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
We produced transgenic (Tg) gnotobiotic (GB) mice carrying human prototype c-Ha-ras genes and compared the incidence of colorectal tumors induced by 1,2-dimethylhydrazine (DMH) injection.
|
9606421 |
1998 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
The principal objective of this study was to assess the feasibility and validity of a qualitative enzyme-linked immunosorbent assay (ELISA) for detecting the four most common ras mutations in human colorectal tumors at the protein (p21ras) level.
|
8625092 |
1995 |
Colorectal Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
K-ras-2 mutations and DNA content heterogeneity represent early events of human colorectal tumor progression.
|
7698570 |
1995 |
Colorectal Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
|
1373678 |
1992 |
Colorectal Neoplasms
|
0.200 |
AlteredExpression
|
group |
BEFREE |
Expression of p21ras in fresh primary and metastatic human colorectal tumors.
|
3885218 |
1985 |